Bacterial Diseases Study Guide PDF

Summary

This document provides a study guide on various bacterial diseases, covering routes of infection, sepsis, and treatment. It includes sections on gram staining, reportable diseases and atypical mycobacterial diseases, useful for students studying medicine and related fields.

Full Transcript

- Routes of infection - Contact - Direct- person to person - Indirect- Person to thing to person - Vector: - Mechanical and biologics; - Vehicle - Food, water, air - Types of pathogens - Viruses, bacteria, fungi, protozoa...

- Routes of infection - Contact - Direct- person to person - Indirect- Person to thing to person - Vector: - Mechanical and biologics; - Vehicle - Food, water, air - Types of pathogens - Viruses, bacteria, fungi, protozoa - Gram staining - Positive is purple, negative is pink - Strep- gram positive chains - Staph- gram positive clusters - Reportable diseases - Must be reported to CDC, collects and reports info weekly - Sepsis - Life-threatening organ dysfunction caused by dysregulated host response to infection - Most common type- vasodilatory shock - Septic shock: - Fluid-unresponsive hypotension (below 100 mmHg) - Serum lactate over 2mmol/L - Need for vasopressors to keep MAP above 65 - Serology - Medical science dealing w/blood serum especially in regard to its immunological rxns and properties - Testing of blood serum to detect presence of antibodies against a specific antigen - Sepsis/shock - Etiology: generally due to gram positive or negative bacteria - Can be viruses and fungi - Risk factors: chronic conditions, weak immune systems, sepsis survivors, adults 65+, children younger than 1-year, recent severe illness or hospitalization - Criteria: - Sequential organ failure assessment- poor sensitivity should not be used a single tool - Systemic inflammatory response syndrome - Temp over 100.4, RR over 20, PCO2 below 32, HR over 90, WBC over 12000 - Sepsis: SIRS + Microbial source - Severe sepsis: Sepsis with \> 1 organ system dysfunction - Septic shock: severe sepsis w/hypotension unresponsiveness to fluid resuscitation - Mods: \>1 organ system requiring interventional homeostasis - Workup - CBC- elevated or decreased WBC, increased bands, thrombocytopenia - CMP- electrolytes, glucose, BUN and creatinine may be high - ABP - Coagulation parameters- may be abnormal or disseminated vascular coagulation - Lactate- repeat in 2 hours or after fluids if high - 2 sets of blood cultures prior to antibiotics if possible - Except for pediatrics- 1 set is generally considered adequate - UA with culture - CXR, EKG - Type and cross may be appropriate - Treatment - Advanced cardiac life support first necessary: circulation, airway, breathing - Two large bore Iv's - Consider central line, broad spectrum antibiotics within 1 hour - Volume replacement- 30 mL/kg either normal saline or lactated ringers - 2L bolus is generally appropriate - Pt who are already fluid overloaded (CHF, kidney, liver) go gentle on fluids - Remove source of infection if possible - Vasopressors- norepinephrine, phenylephrine, epinephrine, dopamine, vasopressin, angiotensin II - Central line preferred - Dopamine not recommended unless pt has significant bradycardia - Vasopressin and angiotensin II are adjunct therapies - Norepinephrine is the initial drug of choice to maintain BP in sepsis - 1-2 mcg/min IV infusion, tritiated to maintain MAP of 65 or higher - Max dose 30 mcg/min - Epinephrine is the drug of choice in anaphylactic shock - 1mcg/min IV infusion titrate to response 1-10 mcg/min typical - Prognosis - Monitor and treat evolving infections appropriately - Especially in high-risk populations - Atypical Mycobacterial disease - Nonmotile, nonspore forming, gram-positive, acid-fast bacteria - Mycobacterium avium- most frequent atypical - Disseminated MAC disease is common in HIV but is rare in immunocompetent pts - Atypical mycobacterial disease more common in cystic fibrosis patients - Symptoms - Common: chronic cough, sputum production, fatigue - Less common: malaise, dyspnea, fever, hemoptysis, weight loss - Diagnosis and treatment - Sputum culture - CXR w/progressive. Persistent infiltrates x2 months, cavitary lesions, and multiple nodular densities - Decision to treat depends on severity of disease in immunocompetent pts - HIV-seronegative pts- clarithromycin or azithromycin, rifampim or rifabutin, and ethambutol- x 12 months - Tuberculosis - Mycobacterium tuberculosis- gram positive, acid fast, nonmotile, nonspore forming - Airborne, droplet transmission - Higher in HIV populations, increase in incidence during COVID due to lack of diagnosis and treatment - Primary TB - Inhaled, bacteria evade alveolar macrophages infection results - Infection occurs, lymphatic and hematologic spread occurs - Healthy pts: T-cells and macrophages contain infection, but often do not eradicate it - Bacteria lies dormant in granulomas for years to decades - Latent TB - TB can be reactivated if the immune system is compromised - Occurs in 5-15% of latent TB pts - Results in active TB - Progressive primary TB - Immune system is unable to contain TB, and it spreads - Resulting in both pulmonary and systemic symptoms - Symptoms - Slowly progressive symptoms - Malaise, anorexia, weight loss, fever, and night sweats, chronic cough, often w/blood-streaked sputum - Lymphadenopathy (especially if extrapulmonary infection) - Physical exam - Productive cough with post-tussive rales in apices of lungs, sputum blood tinged - Previously called: consumption, wasting disease, white plague - Extrapulmonary TB - Can cause symptoms outside of lungs: meningitis, arthritis, lymphadenitis, uveitis, renal disease, liver abscesses, Spinal disease, pericarditis - Work up - Diagnosis based on recovery of M tuberculosis from by culture or RNA/DNA amplification - Positive finding of acid-fast bacteria is not diagnostic as other acid-fast bacteria can colonize respiratory tract - Positive Quant-TB is highly specific but cannot distinguish active and latent disease and should be used in conjunction w/CXR, risk assessment and other tests - Follow up a positive test w/susceptibility testing - Imaging does not reliably differentiate between primary and latent disease - Immunocompromised: more likely to have atypical imaging findings such as miliary TB - Testing for latent TB - Mantoux tuberculin skin test or TB skin test - Specificity is 59% for pts who have already been vaccinated with bacillus Calmette-Guerin - Qant gold- interferon gamma release assay (CD4+ T-cell release of interferon gamma in response to M tuberculosis) - Treatment - Report to local, state authorities - Treatment should be conducted by those w/clinical expertise - Minimizes pt risk off morbidity and mortality - Reduces transmission - Prevents emergence of drug-resistant strains (significant worldwide) - Principles of treatment - Administer multiple meds to which the bacteria is susceptible - Provide safest, most effective treatment for the shortest period - Ensure adherence to therapy - Regimens - 4 month- 8 wks rifapentine, moxifloxacin, isoniazid, pyrazinamide then 9 wks of rifapentine, moxifloxacin, and isoniazid - Management of TB in HIV is complex, Monthy follow up of outpatients is recommended - Prognosis - Main cause of treatment failure is noncompliance - Notifiable disease, reporting is mandated - Anthrax - Bacillus anthracis- gram positive spore forming rod - Produces toxin resulting in ulcer w/black eschar in cutaneous anthrax- least deadly - Treatment: PCN, azithromycin or fluroquinolone if allergy - Must be reported to CDC likely agent for bioterrorism - Botulism - Clostridium botulinum: spore forming, anerobic - Symptoms are due to toxin produced - Most commonly from eating contaminated food (home canned) - Patho - Botulism toxin irreversibly inhibits acetylcholine release - Diplopia, blurred vision - Symptoms - Descending flaccid paralysis progressing to respiratory failure and death without treatment - Work up - Send food for testing if possible - This is a reportable disease, CDC should be contacted - Treatment: Equine serum heptavalent botulism anti-toxin (potassium antagonists) - Clostridia tetani - Reportable disease, gram positive spore forming rod - Same genus as botulinum, C tetani is an obligate anaerobe, ubiquitous in soil - Caused by tetanospasmin, a neurotoxin which inhibits inhibitory neurons - Patients often have history of penetrating injury, does not have to be dirty or contaminated wound - Incubation period 5-15 wks averages 8-12 days - Symptoms and physical exam - Generally, in unvaccinated patients: pain or tingling at injury site, local spasticity, stiffness, dysphagia, irritability - Trismus, risus sardonicus (spasms of the facial muscles) - Opisthotonos (spasms back, abdomen, neck) - Painful convulsions w/minimal stimuli - Sensory exam is normal - Workup and treatment - Diagnosis is clinical - Treatment: 500 units human tetanus immune globin IM within 24 hours - Metronidazole 500 mg IV - Bed rest, avoid excess noise/light, sedate w/benzos- paralysis with curare like agents, mechanical ventilation as necessary - Tetanus does not produce natural immunity, and pts will require full immunization after recovery - Complications and prognosis - Airway obstruction, respiratory arrest, cardiac failure - Contaminated wounds on the face and head are more concerning than other areas of the body, mortality rates higher w/shorter incubation period - Active immunization booster every 10 years, women should receive a Tdap w/each pregnancy (27-30 wks) - DtaP for all children under 7 years, Tdap for adults, there is no longer necessary 2-year gap between dosing Td or Tdap - Acute infectious diarrhea - Under two weeks, inflammatory (bloody/purulent/fever), often caused by invasive, toxin-producing bacterium - Noninflammatory - Watery/non-bloody. Mild self-limited, often caused viral noninvasive toxin producing bacterium - Pursue evaluation only if severe or persisting beyond 1 wk - Causes - Rotavirus, norovirus, adenovirus, SARS-CoV-2, Enterotoxin E coli, staph aureus, Giardia, Vibrio cholera - Dysentery - Invasive bacteria - Shigella-shigellosis-report - Salmonella-salmonellosis- report - Campylobacter- report - Yersinia - Toxin production: clostridioides difficile - Diarrhea - Food poisoning- toxin in contaminated foods - Pregnant women- listeria - Day care- Giardia, Cryptosporidium - Camping or swimming in contaminated water- traveler\'s diarrhea - Recent antibiotics- C difficile - HIV-AIDS-associated diarrhea\\ - Patient evaluation - Distinguish mild vs severe illness - PE: evaluate hydration status, mental status, abdominal tenderness - Diagnostic evaluation includes stool studies - Clostridioides difficile if indicated due to recent antibiotic use or hospitalization - Concerning findings: Fever, WBC \>15000, bloody diarrhea, abdominal pain, more than 6 stools/24 hours, dehydration - Treatment - Rehydrate, avoid fatty food, fiber, milk, caffeine, alcohol, Antidiarrheals like loperamide are generally safe - Avoid anticholinergic meds as this can cause toxic megacolon - Antibiotics? Not recommended, unless pt is severeyly dehydrated or immunocompromised - Cipro 500 mg BID x1-3 days or azithromycin 1 gm once or 500 mg x 3 days - Do not give for shiga-toxin-producing E coli as this can cause hemolytic-uremic syndrome especially children - Recommended for: severe salmonella, shigella, cholera, listeria, C difficile - Campylobacter - Motile gram-neg rods - Dairy cattle and chicken both are reservoirs for campylobacter species - Contaminated food is a common cause of disease - Diagnosis: - Stool sample - Treatment: - Azithromycin 1 gm PO once or 500 mg POx3 days - Systemic infections may require IV antibiotics - This is a reportable illness - Campylobacter fetus - Gram negative rods - C fetus can cause systemic infection that can be fatal including sepsis, meningitis, endocarditis, abscesses - Older immunocompromised or medically fragile - Systemic infections require IV antibiotics- gentamycin, carbapenems, fluoroquinolones/cephalosporins in susceptible organisms - Cholera - Secretory diarrhea- driven by secretion of chloride ions - Reportable disease - Fecal-oral transmission - Symptoms - Voluminous secretory diarrhea, rice water stool, without blood, purulent discharge or odor - Dehydration kills - Risk factors: travel to endemic areas, overcrowding, inadequate sanitization - Diagnosis: - PCR- based stool testing - Treatment: - Fluid replacement PO in mild to moderate disease. Antibiotics and IV lactated ringers in severe disease - Prevention: - Oral cholera vaccines (expensive not widely available), clean water, waste disposal, hygiene - Closteridioides - Antibiotic associated diarrhea- most are not due to C difficile, but nearly all colitis is due to C difficile - Pathogenic C difficile produces toxins: enterotoxin and cytotoxin - Pts often have a history of antibiotic use within the last 8 wks or recent hospitalization - Symptoms: - Greenish, foul smelling, watery diarrhea, rarely bloody - PE: mild left lower abdominal tenderness can be present - Severe disease: WBC \>15000 or higher - Fulminant diseases: hypotension, shock, ileus, megacolon. Often abdominal pain, diarrhea, WBC 30000 - Diagnosis: - Stool testing: - Immunoassay for glutamate dehydrogenase - PCR for C difficile toxin gene - Treatment: - Initial: Fidaxomicin 200 mg PO BIDx10days or vancomycin 125 mg PO QIDx10days. 15-25% recurrence rate with fidaxomicin and vancomycin respectively - First recurrence: fidaxomicin as above or Vancomycin taper - Fulminant disease: Vancomycin 500 mg PO QID and metronidazole 500 mg IV TID. Vanco can be administered via rectal tube and enema in case of ileus - Consult surgery early in fulminant disease - Listeria - Motile, gram-positive rod, listeriosis - Transmission: contaminated food especially deli meats and unpasteurized dairy products (vaginal during birth) - Types of infection - In pregnancy- gastroenteritis - Reportable disease - Symptoms: - Fever, diarrhea, Nausea/vomiting, bloody/purulent diarrhea - Treatment - Ampicillin 8-12 g/day IV divided in 4-6 doses - Single gentamycin 5 mg/kg/day - PCN allergy: trimethoprim-sulfamethoxazole 10-20 mg/day (2-3 wks) - Travelers Diarrhea - Benign, self-limited- large differential - E coli, salmonella, shigella, campylobacter - Prevention: - Good hand hygiene, avoidance of fresh foods which cannot be pealed, drink only bottle or boiled water - Provide antibiotics to healthy pts in case of diarrhea (ciprofloxacin 750 mg once and azithromycin 1000mg PO once if bloody or persistent) - Salmonella - Transmission by ingestion of contaminated food and drink - Can cause enteric fever, gastroenteritis, bacteremia or localized infections - Typhoid fever - Typhi and paratyphoid - Cross the epithelial border invades the macrophages and replicate in the Peyer's patches, mesenteric lymph nodes, and spleen - May disseminate, incubation 6-30 days - Symptoms - Malaise, headache, cough, sore throat, often abdominal pain, constipation then pea soup diarrhea, vomiting - Improves over 7-10 days if no complications - Rose spots - Come up during second week of illness, individual spots principally on trunk 2-3 mm, fades w/pressure, disappears in 3-4 days - Work up - No leukocytosis, Leukopenia possible, transaminitis likely - Best diagnosed on blood culture-80% in first wk of illness - Stool cultures are often negative when the illness develops - Treatment - Ceftriaxone 2g IV for 10-14 days or azithromycin 1g PO once and then 500 mg PO daily for 5-7 days - Complications and prognosis - Appearance of leukocytosis and tachycardia indicates these complications - Intestinal hemorrhage, intestinal perforation - Prevention - Vaccination- oral and IM, not always effective, consider for household contacts travelers and during endemic outbreaks - Salmonella gastroenteritis - Fever, chills, nausea, vomiting, abdominal pain, diarrhea - Symptoms 4-7 dyas and generally, self-limited - Diagnosis: stool culture - Severe infections or immunocompromised individuals use Ciprofloxacin 500 mg PO BID or levofloxacin 500 mg daily for 3-14 days. 14 days if immunocompromised - Complications - Sepsis, localized infections: bone, joints, pleural, pericardium, lungs, and other sites - Shigella - S sonnei, S flexneri, S dysenteriar - Highly transmissible, low ineffective dose, fecal-oral- including oral and anal sex - Increasing antibiotic resistance - Symptoms - Often self-limited and mild, abrupt onset of diarrhea, lower abdominal cramping, and tenesmus - Stool often mixed with blood and mucus - Work Up and Complications - Diagnosis: stool culture, blood cultures rarely positive - Complications: proctitis, intestinal obstruction, and perforation of the colon - Treatment: - In severe or immunocompromised cases attempt to establish susceptibility - Use fluroquinolones- ciprofloxacin 750 mg PO or IV BID, Levofloxacin 500 mg PO daily 3-5 days - High rates of resistance among MSM - Viral causes of Diarrhea - Noninflammatory, rotavirus, norovirus, adenovirus, astrovirus, SARS-CoV-2

Use Quizgecko on...
Browser
Browser